EcoR1 Capital, LLC Quant / Systematic

CIK: 0001587114 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value ($000): $997,012 (100.0% shares, 0.0% debt)

Holdings (31)

ASSEMBLY BIOSCIENCES INC 14.5%
Value ($000) $144,627 Shares 2,943,165 Est. Cost $8.38 Unrealized
ASND ASCENDIS PHARMA 12.0%
Value ($000) $119,196 Shares 1,822,575 Est. Cost $26.79 Unrealized
FIBROGEN INC 9.3%
Value ($000) $92,513 Shares 2,002,437 Est. Cost $36.02 Unrealized
IRWD IRONWOOD PHARMACEUTICALS INC 9.1%
Value ($000) $90,815 Shares 5,885,583 Est. Cost $11.69 Unrealized +6.6%
KURA KURA ONCOLOGY INC 7.1%
Value ($000) $70,628 Shares 3,766,852 Est. Cost $9.78 Unrealized +99.0%
WVE WAVE LIFE SCIENCES LTD 5.9%
Value ($000) $58,509 Shares 1,459,072 Est. Cost $30.27 Unrealized +38.9%
ARRAY BIOPHARMA INC 5.0%
Value ($000) $49,765 Shares 3,049,312 Est. Cost $12.79 Unrealized
DICERNA PHARMACEUTICALS ORD 4.6%
Value ($000) $45,548 Shares 4,764,447 Est. Cost $7.99 Unrealized
MGNX MACROGENICS INC 3.7%
Value ($000) $36,497 Shares 1,450,606 Est. Cost $19.87 Unrealized +22.3%
RCUS ARCUS BIOSCIENCES ORD 3.5%
Value ($000) $34,530 Shares 2,236,387 Est. Cost $16.66 Unrealized 0.0%
CELGENE CORPORATION 3.4%
Value ($000) $34,346 Shares 385,000 Est. Cost Unrealized
APLS APELLIS PHARMACEUTICALS INC 2.3%
Value ($000) $23,356 Shares 1,056,348 Est. Cost $14.72 Unrealized +33.5%
FIVE PRIME THERAPEUTICS ORD 2.1%
Value ($000) $21,311 Shares 1,240,470 Est. Cost $17.18 Unrealized
URGN UROGEN PHARMA ORD 2.0%
Value ($000) $19,990 Shares 402,300 Est. Cost $50.09 Unrealized 0.0%
FIBROGEN INC 1.5%
Value ($000) $15,015 Shares 325,000 Est. Cost Unrealized
IMMUNE DESIGN CORP 1.4%
Value ($000) $14,422 Shares 4,437,600 Est. Cost $3.77 Unrealized
AGIO AGIOS PHARMACEUTICALS ORD 1.4%
Value ($000) $14,144 Shares 172,952 Est. Cost $77.29 Unrealized 0.0%
AKBA AKEBIA THERAPEUTICS ORD 1.4%
Value ($000) $13,580 Shares 1,425,000 Est. Cost $13.99 Unrealized 0.0%
ACHILLION PHARMACEUTICALS INC 1.4%
Value ($000) $13,573 Shares 3,668,307 Est. Cost $3.29 Unrealized
DOVA PHARMACEUTICALS ORD 1.2%
Value ($000) $11,654 Shares 429,729 Est. Cost $27.12 Unrealized
ATYR PHARMA INC 1.1%
Value ($000) $10,579 Shares 3,917,972 Est. Cost $3.81 Unrealized
DBV TECHNOLOGIES ADR REP 0.5 ORD 1.0%
Value ($000) $10,382 Shares 450,000 Est. Cost $23.07 Unrealized
IRONWOOD PHARMACEUTICALS INC 1.0%
Value ($000) $10,305 Shares 667,800 Est. Cost Unrealized
PTGX PROTAGONIST THERAPEUTICS ORD 0.9%
Value ($000) $9,308 Shares 1,083,567 Est. Cost $18.83 Unrealized 0.0%
SYNLOGIC ORD 0.7%
Value ($000) $6,566 Shares 700,000 Est. Cost $9.38 Unrealized
DNLI DENALI THERAPEUTICS INC 0.6%
Value ($000) $6,399 Shares 325,000 Est. Cost $18.97 Unrealized +8.4%
RYTM RHYTHM PHARMACEUTICALS INC 0.6%
Value ($000) $6,339 Shares 318,564 Est. Cost $26.40 Unrealized +0.6%
CRVS CORVUS PHARMACEUTICALS INC 0.5%
Value ($000) $5,416 Shares 469,700 Est. Cost $11.04 Unrealized -14.3%
NEWLINK GENETICS CORP 0.4%
Value ($000) $4,060 Shares 560,000 Est. Cost Unrealized
KINDRED BIOSCIENCES INC 0.2%
Value ($000) $2,151 Shares 248,680 Est. Cost $7.10 Unrealized
GERN GERON ORD 0.1%
Value ($000) $1,488 Shares 350,000 Est. Cost $2.70 Unrealized 0.0%